Retraction
Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
Paper Information
Retraction Details
Citations (4)
4
Total Citations1
Post-Retraction(25.0%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
187
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Comparison of efficacy and safety between loading-dose atorvastatin and rosuvastatin in cerebral infarction
Yanchao Li, Di Zhang, Shuang Liu et al. (9 authors)
American Journal of Translational Research
Published: Jan 2024
1 citation
1 citation
187 days after retraction
Recombinant tissue-type plasminogen activator (rt-PA) effectively restores neurological function and improves prognosis in acute ischemic stroke.
Shouyun Zhang, Dezhen Wang, Lin Li
PubMed
Published: Jan 2023
3 citations
3 citations
178 days before retraction
Retracted: Efficacy of Rosuvastatin Combined with rt‐PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
1 citation
1 citation
178 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025